drugset / Trial / NCT00705900

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

NCT00705900 ↗

Completed 60 enrolled NeoStrata Company, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.

Timeline

Start
2007-01
Primary completion
2008-11
Completion
2008-11

Outcome

Met primary endpoint

paper However, the LCD group had greater mean reductions in PASI scores: 58% vs 37% in the calcipotriene group (p < 0.05) at week 12. PMID 20513160 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 0.005 % Topical
Subject liquor carbonis distillate Unknown 15 % Topical

Indications